Annika Bansal – Lifestyle
Author:
Zealand Pharma
Zealand Pharma Establishes U.S. Research Hub in Cambridge, Massachusetts to Expand Drug Discovery Capabilities and Accelerate Medicine Creation
March 24, 2026
Zealand Pharma increases its share capital as a result of the exercise of employee warrants
March 19, 2026
Zealand Pharma to participate in upcoming investor conferences in March 2026
March 9, 2026
Zealand Pharma announces positive Phase 2 results for petrelintide, an amylin analog with potential to redefine the weight management experience for people living with overweight and obesity
March 6, 2026
←
Previous Page
1
2